Fresenius Medical Care AG

FME

DE0005785802

Healthcare Facilities & Services

Real-time Estimate Tradegate Other stock markets 10:23:10 2024-09-19 am EDT			5-day change	1st Jan Change
37.16 ^EUR	-0.68%		+2.59%	-1.92%

Sep. 16	FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Jefferies keeps a Sell rating	ZD
Sep. 16	Fresenius Medical Care AG - Special Call

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan maintains a Sell rating

August 07, 2024 at 04:01 am EDT

JP Morgan's analyst David Adlington maintains his Sell rating on the stock. The target price is unchanged and still at EUR 35.40.

Latest news about Fresenius Medical Care AG

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Jefferies keeps a Sell rating	Sep. 16	ZD
Fresenius Medical Care AG - Special Call	Sep. 16
Fresenius at high since May 2022 after JPMorgan recommendation	Sep. 13	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Receives a Buy rating from Berenberg	Sep. 11	ZD
Everything will probably stay the same in the Dax - No relegated stocks	Aug. 29	RE
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Jefferies maintains a Sell rating	Aug. 08	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan maintains a Sell rating	Aug. 07	ZD
Fitch Affirms Fresenius Rating, Revises Outlook to Stable on Improving Profitability	Aug. 05	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs reiterates its Buy rating	Aug. 01	ZD
Frankfurt equities close: Cautious optimism ahead of US interest rate decision	Jul. 31	DP
Truist Adjusts Fresenius Medical Care's PT to $22 From $24 After Mixed Q2 Results, Keeps Hold Rating	Jul. 31	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays sticks Neutral	Jul. 31	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Buy rating from Berenberg	Jul. 31	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Neutral rating from UBS	Jul. 31	ZD
Fresenius earns significantly more in the quarter - beats expectations	Jul. 31	DP
FRESENIUS MEDICAL CARE : Strong figures but disappointment on the US	Jul. 31
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from JP Morgan	Jul. 31	ZD
Fresenius beats Q2 expectations on strong unit performance, cost savings	Jul. 31	RE
Frankfurt shares close: Gains ahead of Microsoft figures and Fed	Jul. 30	DP
Global markets live: Diageo, Apple, Tesla, Meta Platforms, PayPal, Pfizer...	Jul. 30
Weak US growth forecast weighs on FMC - shares down	Jul. 30	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : DZ Bank remains Neutral	Jul. 30	ZD
Sector Update: Health Care Stocks Advance Premarket Tuesday	Jul. 30	MT
Sector Update: Health Care	Jul. 30	MT
Fresenius Medical Care AG & Co. KGaA, Q2 2024 Earnings Call, Jul 30, 2024	Jul. 30

Chart Fresenius Medical Care AG

Duration

Period

More charts

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Employees

113,639

Sector

Healthcare Facilities & Services

Calendar

2024-09-24 - Bernstein Pan European Strategic Decisions Conference

More about the company